PTR-15481-82852
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 060 / CT
- Registered
- 2021-11-21
- Relationship
- Child or adolescent in my care
- Guardian
- 8PR-18482-11900
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-20
Dose 1 — Pfizer-BioNTech
-
2021-11-21
Registered in v-safe
-
2021-11-21
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Eye pruritus — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Eye itchy (left)MedDRA releases: 2024-11 · check-in free text available
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-12-04
- 2021-12-13
-
2021-12-18
Dose 2 — Pfizer-BioNTech
-
2021-12-18
Health check-in — day 0, dose 2, dependentFeeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-01-22
- 2022-01-31
-
2022-03-19
Survey response — 3 months, dose 2, dependentMedDRA: Asthma, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Asthma exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2022-03-19
Report sent to call center — 3 months, dose 2, dependentGet care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-22
- 2022-06-24
-
2022-12-20
Survey response — 12 months, dose 2, dependentMedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Covid positive 9/24/22 (third time in 2022).MedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 12 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-21
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-20 | Pfizer-BioNTech | No |
| 2 | 2021-12-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Eye itchy (left)
Release 11 — 3 months, dose 2, dependent
Symptoms: Asthma exacerbation
Release 12 — 12 months, dose 2, dependent
Symptoms: Covid positive 9/24/22 (third time in 2022).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Eye pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release